DK0921117T3 - Guanidinforbindelser - Google Patents
GuanidinforbindelserInfo
- Publication number
- DK0921117T3 DK0921117T3 DK99102583T DK99102583T DK0921117T3 DK 0921117 T3 DK0921117 T3 DK 0921117T3 DK 99102583 T DK99102583 T DK 99102583T DK 99102583 T DK99102583 T DK 99102583T DK 0921117 T3 DK0921117 T3 DK 0921117T3
- Authority
- DK
- Denmark
- Prior art keywords
- trifluoromethyl
- hydrogen
- fluoro
- chloro
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4328352A DE4328352A1 (de) | 1993-08-24 | 1993-08-24 | Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK0921117T3 true DK0921117T3 (da) | 2004-04-13 |
| DK0921117T4 DK0921117T4 (da) | 2009-05-11 |
Family
ID=6495834
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99102583T DK0921117T4 (da) | 1993-08-24 | 1994-08-18 | Guanidinforbindelser |
| DK94112895T DK0640587T3 (da) | 1993-08-24 | 1994-08-18 | Diacylsubstituerede guanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnostisk mid |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94112895T DK0640587T3 (da) | 1993-08-24 | 1994-08-18 | Diacylsubstituerede guanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnostisk mid |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US6436999B1 (da) |
| EP (2) | EP0921117B2 (da) |
| JP (2) | JP3790557B2 (da) |
| AT (2) | ATE188208T1 (da) |
| AU (3) | AU692776B2 (da) |
| CA (2) | CA2130703C (da) |
| DE (3) | DE4328352A1 (da) |
| DK (2) | DK0921117T4 (da) |
| ES (2) | ES2210872T5 (da) |
| FI (1) | FI120390B (da) |
| GR (1) | GR3032685T3 (da) |
| HK (2) | HK1011964A1 (da) |
| HU (1) | HU223055B1 (da) |
| NO (1) | NO302569B1 (da) |
| NZ (1) | NZ264282A (da) |
| PT (2) | PT640587E (da) |
| TW (1) | TW469265B (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
| DE19633966A1 (de) * | 1996-08-22 | 1998-02-26 | Hoechst Ag | Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| JP2002502414A (ja) * | 1997-06-02 | 2002-01-22 | 藤沢薬品工業株式会社 | 細胞中のＮａ▲上＋▼／Ｈ▲上＋▼交換の阻害剤としてのグアニジン誘導体 |
| CN1307571A (zh) * | 1998-04-24 | 2001-08-08 | 藤泽药品工业株式会社 | 胍衍生物 |
| DE19859727A1 (de) | 1998-12-23 | 2000-06-29 | Aventis Pharma Gmbh | Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung |
| DE10036002A1 (de) | 2000-07-25 | 2002-02-14 | Aventis Cropscience Gmbh | Herbizide Mittel |
| CA2524718A1 (en) * | 2003-05-06 | 2004-11-18 | Michael Kirschbaum | Method for crystallizing guanidinium salts |
| GB0520405D0 (en) * | 2005-10-07 | 2005-11-16 | Imp College Innovations Ltd | Biological agents and method |
| EP1844654A1 (de) | 2006-03-29 | 2007-10-17 | Bayer CropScience GmbH | Penetrationsförderer für agrochemische Wirkstoffe |
| DE102007013362A1 (de) | 2007-03-16 | 2008-09-18 | Bayer Cropscience Ag | Penetrationsförderer für herbizide Wirkstoffe |
| WO2009110942A2 (en) * | 2007-12-12 | 2009-09-11 | Cernofina, Llc | Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins |
| US20240000946A1 (en) * | 2020-12-03 | 2024-01-04 | Vilnius University | Carbonic anhydrase inhibitors synthesized on interconnecting linker chains |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4206216A (en) | 1976-02-13 | 1980-06-03 | Merck & Co., Inc. | Antihypertensive N-heterocyclicalanines |
| US4065572A (en) | 1976-02-13 | 1977-12-27 | Merck & Co., Inc. | Amino acids and esters thereof useful as antihypertensive agents |
| US4156734A (en) | 1976-02-13 | 1979-05-29 | Merck & Co., Inc. | Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid |
| US4170654A (en) | 1976-02-13 | 1979-10-09 | Merck & Co., Inc. | Antihypertensive compositions containing N-heterocyclicalanines and α- |
| US4160835A (en) | 1976-11-19 | 1979-07-10 | Merck & Co., Inc. | Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid |
| GB1588096A (en) * | 1978-05-20 | 1981-04-15 | Wyeth & Bros Ltd John | Pyrrole derivatives |
| US4271187A (en) | 1978-06-05 | 1981-06-02 | Merck & Co., Inc. | Substituted phenyl alanine antihypertensive agents |
| US4544670A (en) * | 1982-08-24 | 1985-10-01 | William H. Rorer, Inc. | Method of treating coccidiosis with acyl guanidines |
| DE3929582A1 (de) | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| ATE158278T1 (de) * | 1992-02-15 | 1997-10-15 | Hoechst Ag | Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
| DE59305042D1 (de) * | 1992-09-22 | 1997-02-20 | Hoechst Ag | Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika |
| EP0604852A1 (de) * | 1992-12-28 | 1994-07-06 | Hoechst Aktiengesellschaft | 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters |
| DE4404183A1 (de) | 1994-02-10 | 1995-08-17 | Merck Patent Gmbh | 4-Amino-1-piperidylbenzoylguanidine |
| DE4421495A1 (de) | 1994-06-20 | 1995-12-21 | Merck Patent Gmbh | Heterocyclyloxy-benzoylguanidine |
| DE4430213A1 (de) | 1994-08-28 | 1996-02-29 | Merck Patent Gmbh | Arylbenzoylguanidine |
| DE4430861A1 (de) | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
| DE4430916A1 (de) | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl-benzoylguanidin-Derivate |
| DE4437874A1 (de) | 1994-10-22 | 1996-04-25 | Merck Patent Gmbh | Alkyl-5-methylsulfonyl-benzoylguanidin-Derivate |
| DE19502644A1 (de) | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | 4-Amino-benzoylguanidin-Derivate |
| DE19502895A1 (de) | 1995-01-31 | 1996-08-01 | Merck Patent Gmbh | 4-Mercapto-benzoylguanidin-Derivate |
| DE19517848A1 (de) | 1995-05-16 | 1996-11-21 | Merck Patent Gmbh | Fluorhaltige Benzoylguanidine |
| DE19529612A1 (de) | 1995-08-11 | 1997-02-13 | Merck Patent Gmbh | Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate |
| DE19531138A1 (de) | 1995-08-24 | 1997-02-27 | Merck Patent Gmbh | Alkenyl-benzoylguanidin-Derivate |
| DE19548708A1 (de) | 1995-12-23 | 1997-06-26 | Merck Patent Gmbh | Cyclische Sulfone |
| US6140563A (en) | 1999-03-04 | 2000-10-31 | Novartis Ag | Inbred maize line NP2151 |
| US6410563B1 (en) * | 1999-12-22 | 2002-06-25 | Merck Frosst Canada & Co. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| MY123585A (en) | 2000-03-23 | 2006-05-31 | Merck Canada Inc | Tri-aryl-substituted-ethane pde4 inhibitors. |
-
1993
- 1993-08-24 DE DE4328352A patent/DE4328352A1/de not_active Withdrawn
-
1994
- 1994-08-18 DE DE59410343T patent/DE59410343D1/de not_active Expired - Lifetime
- 1994-08-18 ES ES99102583T patent/ES2210872T5/es not_active Expired - Lifetime
- 1994-08-18 AT AT94112895T patent/ATE188208T1/de active
- 1994-08-18 ES ES94112895T patent/ES2142895T3/es not_active Expired - Lifetime
- 1994-08-18 PT PT94112895T patent/PT640587E/pt unknown
- 1994-08-18 EP EP99102583A patent/EP0921117B2/de not_active Expired - Lifetime
- 1994-08-18 DE DE59409032T patent/DE59409032D1/de not_active Expired - Lifetime
- 1994-08-18 PT PT99102583T patent/PT921117E/pt unknown
- 1994-08-18 DK DK99102583T patent/DK0921117T4/da active
- 1994-08-18 AT AT99102583T patent/ATE256105T1/de active
- 1994-08-18 DK DK94112895T patent/DK0640587T3/da active
- 1994-08-18 EP EP94112895A patent/EP0640587B1/de not_active Expired - Lifetime
- 1994-08-22 NZ NZ264282A patent/NZ264282A/en not_active IP Right Cessation
- 1994-08-22 FI FI943853A patent/FI120390B/fi not_active IP Right Cessation
- 1994-08-22 AU AU70397/94A patent/AU692776B2/en not_active Ceased
- 1994-08-23 NO NO943111A patent/NO302569B1/no not_active IP Right Cessation
- 1994-08-23 JP JP21963594A patent/JP3790557B2/ja not_active Expired - Fee Related
- 1994-08-23 CA CA002130703A patent/CA2130703C/en not_active Expired - Lifetime
- 1994-08-23 CA CA002546602A patent/CA2546602C/en not_active Expired - Lifetime
- 1994-08-24 HU HU9402444A patent/HU223055B1/hu active IP Right Grant
- 1994-09-17 TW TW083107527A patent/TW469265B/zh not_active IP Right Cessation
-
1997
- 1997-04-18 US US08/837,460 patent/US6436999B1/en not_active Expired - Fee Related
-
1998
- 1998-05-19 AU AU67114/98A patent/AU6711498A/en not_active Withdrawn
- 1998-06-23 AU AU73143/98A patent/AU707538B2/en not_active Ceased
- 1998-12-10 HK HK98113033A patent/HK1011964A1/xx not_active IP Right Cessation
- 1998-12-10 HK HK99105619A patent/HK1021529A1/xx not_active IP Right Cessation
-
2000
- 2000-02-18 GR GR20000400383T patent/GR3032685T3/el unknown
- 2000-03-24 US US09/534,036 patent/US6632840B1/en not_active Expired - Fee Related
-
2001
- 2001-07-25 JP JP2001224010A patent/JP3775730B2/ja not_active Expired - Fee Related
-
2003
- 2003-08-15 US US10/641,058 patent/US20040044081A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0921117T4 (da) | Guanidinforbindelser | |
| DE69839735D1 (de) | Pyrimidin-5-carboxamid-derivate | |
| AU8122791A (en) | Benzimidazoles | |
| DE69628804D1 (de) | Substitutierte heterozyclische Derivate als CRF Antagonisten | |
| ES2107447T3 (es) | Ftalidas substituidas y ftalidas heterociclicas. | |
| ATE227719T1 (de) | Heteroaryl-zyklische acetale | |
| ES2176311T3 (es) | Nuevos derivados imidazol y procedimiento para su preparacion. | |
| DE69813605D1 (de) | Benzofuranderivate | |
| MY112411A (en) | Indole derivatives. | |
| EA199900163A1 (ru) | Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств | |
| NO930205L (no) | Benzimidazoler, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
| ES2120498T3 (es) | Nuevo compuesto tetraciclico. | |
| DE69526097D1 (de) | Bicyclische carboxamide als 5-ht1a rezeptoren liganden | |
| MX9603762A (es) | N-(arilmetil-sustituidas)-4-[bis-(fenil-sustituidas)metil]piperidina insecticidas. |